VICETON® is a broad-spectrum antibiotic,
indicated for the following conditions in dogs:
infections of the respiratory tract and urinary
tract, enteritis, and infections associated with
canine distemper.

•
•
•

See reverse side for Administration and Dosage.

PACKAGING
UNIT PACKAGE

CASE SIZE

1VIC002

LIST NO.

1 gm 100 ct

12

1VIC004

250 mg 500 ct

12

1VIC005

500 mg 500 ct

12

•
•

Fast: Diffuses readily into all body tissues and fluids.
Reaches infected tissue very rapidly.
Easy to administer: Tablets are small, scored, and
coated for easy pilling.
Effective:
• Provides rapid clinical response against a wide
range of pathogens.
• Most susceptible infectious disease organisms
will respond to chloramphenicol therapy in three
to five days
• Reaches significant concentrations in the aqueous
and vitreous humors of the eye and has marked
ability to diffuse into the cerebrospinal fluid.
Low resistance: Resistance is rare compared with
other antibiotics.
FDA Approved

INDICATIONS
Chloramphenicol Tablets are recommended for oral treatment of
the following conditions in dogs:
• Bacterial pulmonary infections caused by susceptible
microorganisms such as: Staphylococcus aureus,
Streptococcus pyogenes and Brucella bronchiseptica.
• Infections of the urinary tract caused by susceptible
microorganisms such as: Escherichia coli, Proteus vulgaris,
Corynebacterium renale, Streptococcus spp., and hemolytic
Staphylococcus.
• Enteritis caused by susceptible microorganisms such as: E.
coli, Proteus spp., Salmonella spp., and Pseudomonas spp.
• Infections associated with canine distemper caused by
susceptible microorganisms such as: B. bronchiseptica, E.
coli, P. aeruginosa, Proteus spp., Shigella spp. and Neisseria
catarrhalis.
Additional adjunctive therapy should be used when indicated.
Most susceptible infectious disease organisms will respond to
chloramphenicol therapy in three to five days when the recommended
dosage regimen is followed. If no response to chloramphenicol
therapy is obtained in three to five days, discontinue its use
and review the diagnosis. Also, a change of therapy should be
considered.
Laboratory tests should be conducted including in vitro culturing
and susceptibility tests on samples collected prior to treatment.
CONTRAINDICATIONS
Because of potential antagonism, chloramphenicol should not be
administered simultaneously with penicillin or streptomycin.
WARNING
NOT FOR USE IN ANIMALS WHICH ARE RAISED FOR FOOD
PRODUCTION.
1. CHLORAMPHENICOL PRODUCTS SHOULD NOT BE
ADMINISTERED IN CONJUNCTION WITH OR TWO HOURS
PRIOR TO THE INDUCTION OF GENERAL ANESTHESIA WITH
PENTOBARBITAL BECAUSE OF PROLONGED RECOVERY
TIME.
2. CHLORAMPHENICOL PRODUCTS SHOULD NOT BE
ADMINISTERED TO DOGS MAINTAINED FOR BREEDING
PURPOSES. SOME EXPERIMENTS INDICATE THAT
CHLORAMPHENICOL CAUSES, IN EXPERIMENTAL ANIMALS,
PARTICULARLY FEMALES, SIGNIFICANT DISORDERS IN
MORPHOLOGY AS WELL AS IN FUNCTION OF THE GONADS.

ADVERSE REACTIONS
Certain individual dogs may exhibit transient vomiting or diarrhea
after an oral dose of 25 mg/lb. body weight.
PRECAUTIONS
1. THIS ANTIBIOTIC CONTAINS A CHEMICAL STRUCTURE
(NITROBENZENE GROUP) THAT IS CHARACTERISTIC OF A
GROUP OF DRUGS LONG KNOWN TO DEPRESS HEMATOPOIETIC
ACTIVITY OF THE BONE MARROW.
2. IN VITRO TISSUE CULTURE STUDIES USING CANINE BONE
MARROW CELLS HAVE DEMONSTRATED THAT EXTREMELY
HIGH CONCENTRATIONS OF CHLORAMPHENICOL INHIBIT
BOTH UPTAKE OF IRON BY THE NUCLEATED RED CELLS AND
INCORPORATION OF IRON INTO HEME.
DOSAGE AND ADMINISTRATION
Dogs—25 mg/lb. body weight every 6 hours for oral administration.
CAUTION
Federal law restricts this drug to use by or on the order of a licensed
veterinarian.
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
STORAGE
Store at or below 25°C (77°F) in a dry place.
HOW SUPPLIED
250 mg Bottles of 500’s
500 mg Bottles of 500’s
1 gram Bottles of 100’s